zeronil vet. 402 mg spot-on, opløsning
chanelle pharmaceutical man. ltd - fipronil - spot-on, opløsning - 402 mg
zeronil vet. 50 mg spot-on, opløsning
chanelle pharmaceutical man. ltd - fipronil - spot-on, opløsning - 50 mg
zeronil vet. 67 mg spot-on, opløsning
chanelle pharmaceutical man. ltd - fipronil - spot-on, opløsning - 67 mg
equicam 15 mg/ml oral suspension
chanelle pharmaceuticals manufacturing limited - meloxicam - oral suspension - 15 mg/ml - hest
zepromec 5 mg/ml pour-on, opløsning
chanelle pharmaceuticals manufacturing limited - eprinomectin - pour-on, opløsning - 5 mg/ml - kvæg
zerofen vet. 4% oralt pulver
chanelle pharmaceuticals manufacturing limited - fenbendazol - oralt pulver - 4% - svin
fulvestrant mylan
mylan pharmaceuticals limited - fulvestrant - bryst neoplasmer - endokrine terapi - fulvestrant er indiceret til behandling af østrogen receptor positiv, lokalt fremskreden eller metastatisk brystkræft hos postmenopausale kvinder:ikke tidligere behandlet med endokrin terapi, orwith disease, tilbagefald eller efter adjuverende anti-østrogen behandling eller af sygdomsprogression på antiøstrogen terapi.
dycoxan 2,5 mg/ml oral suspension
chanelle pharmaceuticals manufacturing limited - diclazuril - oral suspension - 2,5 mg/ml
milbetab 12,5+125 mg tabletter
chanelle pharmaceuticals manufacturing limited - milbemycinoxim, praziquantel - tabletter - 12,5+125 mg
milipraz 12,5+125 mg tabletter
chanelle pharmaceuticals manufacturing limited - milbemycinoxim, praziquantel - tabletter - 12,5+125 mg